fbpx Digital Technologies of Tomorrow QuickFire Challenge - Challenge | JLABS
Digital Technologies of Tomorrow
3420_Johnson_and_Johnson_Jlabs_Wechats_QFC_Intro_English_2021_01-11_Captions-v3

Digital Technologies of Tomorrow QuickFire Challenge

Challenge ended

Grant funding from a total of up to $100,000

                        点击这里阅读中文

Overview

Emerging technologies in AI, IoT, and 3DP may shape the future of healthcare in China and beyond. To improve health outcomes, advancing digital technology innovation could be central to China’s Health 2030 mandate.[1] Furthermore, the 2019 Future of Health Index identifies China as a ‘forerunner’ in adoption of new technologies in healthcare.[2]

Unlocking the promise of health technologies could be the key to bringing forward transformative potential breakthroughs for the patients who need them most.

To that end, Johnson & Johnson Innovation together with Johnson & Johnson Medical Shanghai are proud to introduce the Digital Technologies of Tomorrow QuickFire Challenge. Visionaries are invited to submit novel, medical device ideas with the potential to transform patient care in AFIB, neurovascular treatments, orthopedic and general surgery.

The innovator(s) with the best idea(s) will receive grant funding from a total of up to $100,000, one year of residency at JLABS @ Shanghai, and mentorship from experts of the Johnson & Johnson Family of Companies.

 

[1] https://www.who.int/healthpromotion/conferences/9gchp/healthy-china/en/
[2] https://www.philips.com/a-w/about/news/future-health-index/reports/2019/transforming-healthcare-experiences.html

 

Areas of Interest

We encourage applications from entrepreneurs & innovators working with the aim to harness medical device technologies such as Artificial Intelligence (AI), 3D-printing, IoT, 5G, and beyond in diagnostics, perioperative treatment solutions, and emerging and transformative technologies, related specifically to:

  • AFIB: How can we leverage digital technologies with the aim to identify patients and refer them to the appropriate physicians? How can we trace patients for remission after treatment?
  • Neurovascular Treatments: How can we detect signs/ risks of stroke for early treatment?
  • General and orthopedic surgery, including distant operating stage support and AI-enabled procedure planning:  How can we drive more effective potential perioperative solutions (including pre-, intra- and post-surgery) with emerging technologies? How can we apply innovative, untraditional material to orthopedics surgery?

Awards

Grant Funding from a total of up to $100,000
  • Residency at JLABS @ Shanghai including workstation and access to the JLABS ecosystem
  • Mentorship from experts of the Johnson & Johnson Family of Companies.

Why this challenge matters to us

We believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that aim to provide potential solutions to patients from around the world. Working together, we can spark the next great idea that could change the trajectory of health.

Criteria

Submissions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria: 

  • Problem space and potential impact 
  • Ability to drive immediate impact beyond current solutions 
  • Uniqueness of potential solution & level of competition in the current market 
  • Quality & feasibility of the potential solution to commercialize within 12 months 
  • Team credibility & capabilities 
  • Clarity of plan: milestones & defined go/no 
  • Potential impact on Chinese ecosystem 

Apply Now

Submit your idea today! 


Don’t miss the deadline

FAQs

What if I’m having trouble accessing the portal/website?

Make sure your browser is up to date and accepting cookies.

Can I submit supporting documents (for example a video) as part of my application?

You will have the opportunity and are encouraged to upload supporting materials such as slide decks, research papers, and videos as part of your application. You may submit a video along with your typed responses. Maximum length is two minutes.

Is it ok if some of the information I submit is confidential?

Do not submit confidential information. Only non-confidential information should be submitted and anything you submit will be treated as non-confidential.

What happens with IP (Intellectual Property)?

As this is a no-strings-attached arrangement, JLABS does not acquire any IP. Any IP creation and/or protection remains the sole responsibility of the inventors.

 

Is a patent required to apply?

No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.

What kind of science / technology is appropriate for the Challenges?

We encourage applications from entrepreneurs & innovators working with the aim to harness medical device technologies such as Artificial Intelligence (AI), 3D-printing, IoT, 5G, and beyond in treatment pathways, diagnostics, emerging and transformative technologies, related specifically to:

  • AFIB
  • Neurovascular
  • General and orthopedic surgery, including distant operating stage support and AI-enabled procedure planning

Who is eligible to apply?

Each Challenge has its own terms & conditions that can be found prior to filling out the application.

 

Do applicants have to reside in China in order to apply?

No, this is a global challenge.

Who can I contact if I have questions about the Challenges or the application process?

Please contact [email protected] with any questions.

Where do I apply? And do I have to complete the application in one sitting?

Go to https://jnjquickfire.secure-platform.com to learn more. From there you will be directed to set up an account. You are able to save your work and log back in to finish at a later time if needed.

Timeline

January 13, 2021
Applications Open
March 22, 2021
Submission Deadline
Spring 2021
Award Announcement

About Johnson & Johnson Innovation

Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.

About Johnson & Johnson Innovation - JLABS

Johnson & Johnson InnovationJLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.

Picture1_0.png

强生公司

强生是全球业务分布广泛、综合性的跨国医疗保健企业,业务涉及消费品、制药、医疗器材三大领域,1985年在华创立了第一家合资企业。强生遵循企业信条的价值观,致力于践行“关爱全世界,关注每个人”的健康愿景,以领先的科技研发创造创新的理念、产品和服务,为改善人类健康和福祉而不懈努力。每天,强生遍布世界各地的员工,与他们的合作方一起,为全球消费者和病患带来更健康、更快乐、更长寿的生活。